Abstract 17110: Baxdrostat in Uncontrolled or Resistant Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Introduction: Resistant hypertension remains difficult to control and is associated with increased cardiovascular and renal risk. Baxdrostat, a selective aldosterone synthase inhibitor, has emerged as a potential therapeutic option for adults with uncontrolled or resistant hypertension. We evaluated the efficacy and...